Anti-Human CD49d Antibody: Enhance Your Research with Quality Solutions

Discover the groundbreaking Anti human CD49d Antibody developed by Alpha Lifetech Incorporation. This highly specific monoclonal antibody is designed to target the Cd49d protein, a critical molecule involved in the regulation of immune responses and inflammatory processes. With its exceptional binding affinity and minimal off-target effects, our Anti Human Cd49d Antibody offers a reliable tool for studying the function of Cd49d in various biological processes, Our Antibody is rigorously validated for use in applications such as flow cytometry, immunohistochemistry, and Western blotting, providing researchers with the confidence and accuracy needed for their experiments. Whether you are investigating autoimmune diseases, cancer metastasis, or immunotherapy, our Anti Human Cd49d Antibody is an essential tool for understanding the role of Cd49d in these complex biological pathways, At Alpha Lifetech Incorporation, we are committed to delivering high-quality reagents that empower scientific discovery. Join the countless researchers who trust our Anti Human Cd49d Antibody for their studies. Explore the potential of this innovative tool and elevate your research to new heights

Hot Selling Product

ALP64509-Recombinant Human Siglec-10 Protein, mFc Tag

ALP64521-Recombinant Human CD172a/SHPS-1/SIRPA Protein, His Tag, Avi Tag

ALP64537-Recombinant Human CD28 Protein, His Tag

ALP64557-Recombinant Human CD40L/TNFRSF5 Protein, mFc Tag

ADT1742-Human Anti-Her2xHer3 Bispecific Antibody

ADT1744-Human Anti-VEGFAxANGPT2 Bispecific Antibody

Ultimate Guide To Anti Human Cd49d Antibody Guarantees Peak Performance Service

In the world of biomedical research and therapeutics, the demand for high-quality antibodies is paramount. At Alpha Lifetech Inc., we understand that the success of your experiments hinges on the reliability and performance of your reagents. This is where our Anti-Human CD49d Antibody comes into play. Engineered by a team of expert scientists with extensive backgrounds in membrane protein production and monoclonal development, our antibody guarantees peak performance, helping you achieve accurate and reproducible results in your research. Our Anti-Human CD49d Antibody is meticulously developed to ensure the highest specificity and sensitivity, making it an essential tool for immunological applications. With nearly 10,000 high-quality membrane protein reagents and antibodies in our catalog, you can trust that we provide products that not only meet but exceed industry standards. Whether you are studying cell adhesion, immune response, or therapeutic targets, our antibodies come with extensive validation data, ensuring they deliver consistent results every time. By choosing Alpha Lifetech Inc., you are not just purchasing an antibody; you are partnering with a company dedicated to advancing scientific research. Our commitment to excellence is reflected in our rigorous quality control processes and our ongoing support for researchers globally. Experience the difference with our Anti-Human CD49d Antibody and elevate the success of your projects today.

Ultimate Guide To Anti Human Cd49d Antibody Guarantees Peak Performance Service

Parameter	Description	Value
Isotype Control	Target specificity control for validation	IgG1, kappa
Target Antigen	CD49d (Integrin alpha-4)	Human
Application	Western Blot, Flow Cytometry	Yes
Clone Number	Specific clone identifier	5D2
Concentration	Antibody concentration in solution	1.0 mg/mL
Storage Conditions	Optimal storage temperature	-20°C
Cross-Reactivity	Known reactivity with other species	Non-human primates
Recommended Dilution	Dilution factor for assays	1:100

Comparative Analysis of Anti-Human CD49d Antibody Efficacy across Different Applications

This chart presents a comparative analysis of the efficacy of Anti-Human CD49d antibody across various applications pertinent to immunological studies. As illustrated, the highest efficacy is observed in Cell Adhesion assays, reaching 85%, which signifies the antibody's potential in promoting or inhibiting cellular interactions crucial for immune responses. Following closely is Cytokine Production with 90%, underscoring its role in modulating immune signaling. Migration Inhibition shows a moderate efficacy of 70%, indicative of the antibody's effectiveness in controlling cellular movement in the context of inflammation and cancer Spread. Immune Response Modulation has relatively lower efficacy at 60%, suggesting room for improvement in enhancing immune functions. Lastly, the Tumor Microenvironment aspect showcases a robust efficacy at 75%, highlighting the antibody's relevance in tumor biology. Overall, these findings depict the versatility and wide-ranging applications of Anti-Human CD49d antibodies in research and therapeutic fields.